CALR and cancer: Based on our above preclinical findings, indicating that low endogenous levels of CRT could be a crucial cell autonomous factor compromising AVE potential; we set out to determine whether, a subset of patients of various cancer types could show reduced or low tumoural expression levels of CRT/CALR.